— Know what they know.
Not Investment Advice

NUGS OTC

Cannabis Strategic Ventures
1W: -18.4% 1M: -47.0% 3M: +610.0% YTD: +1083.3% 1Y: +7000.0% 3Y: -52.0% 5Y: -90.5%
$0.01
-0.00 (-2.74%)
 
Weekly Expected Move ±33.2%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · $2.6M mcap · 368M float · 0.267% daily turnover · Short 43% of daily vol

Income Trends

Revenue
$10M -32.5% ▼
Gross Profit
$922K -66.9% ▼
Operating Income
-$7M -36.2% ▼
Net Income
-$9M -52.5% ▼
EPS (Diluted)
$-0.03 -32.9% ▼
EBITDA
-$6M -13.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$345K$702K$2M$15M$10M
YoY Growth+0.0%+103.6%+237.2%+516.6%-32.5%
Cost of Revenue$96K$681K$2M$12M$9M
Gross Profit$249K$21K$477K$3M$922K
Gross Margin72.1%3.0%20.1%19.1%9.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$5M$21M$7M$8M$8M
Operating Expenses$5M$21M$9M$8M$8M
Operating Income-$4M-$21M-$9M-$5M-$7M
Operating Margin-1291.0%-3008.1%-362.4%-36.3%-73.3%
Interest Expense$922$0$41K$321K$1M
Income Before Tax-$617K-$21M-$9M-$6M-$9M
Tax Expense$2K$0$0$0$0
Net Income-$8M-$21M-$9M-$6M-$9M
Net Margin-2439.8%-3053.3%-382.6%-38.6%-87.3%
EPS (Diluted)$-0.00$-0.08$-0.04$-0.02$-0.03
EBITDA-$6M-$21M-$9M-$5M-$6M
Shares Outstanding193M268M248M273M312M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms